Recent estimates indicate up to 60% of lameness problems in horses are associated with arthritis,1 making it the most common cause of equine lameness. As horses live longer,2 veterinarians and owners are looking for ways to help maintain soundness by addressing mobility issues early. Proactively seeking a veterinarian’s diagnosis and treatment when injury or disease occurs is key to maximizing and maintaining healthy joints over your horse’s career and life span.
If your horse is diagnosed with arthritis, your veterinarian may recommend an approach that includes Adequan® i.m. (polysulfated glycosaminoglycan), the only medication available that’s proven to proactively treat the disease and not just the symptoms of arthritis.3
Commonly diagnosed as degenerative joint disease (DJD), equine arthritis is a painful disease characterized by progressive deterioration of joint cartilage and changes in bone and soft tissues of the joint.4
Cartilage is a highly specialized connective tissue in a horse’s joints that helps bones glide over each other. Because cartilage is subjected to the daily wear and tear of every movement, it is prone to progressive deterioration over time. Plus, it contains no blood vessels, lymphatics or nerves, giving it a limited capacity to heal and repair. Once cartilage wears away completely, it cannot be restored. That’s why maintaining healthy cartilage is paramount to keeping joints healthy.
Once cartilage is eroded, bone-on-bone contact can occur, causing pain and abnormal wear and tear on joints.
Whether a horse is a 2-year-old in training, a mature weekend warrior or a geriatric companion, proactive collaboration between veterinarians, owners and trainers to identify and manage arthritis is pivotal to healthy longevity—and mobility.
When you start with and stay with Adequan i.m., your horse may enjoy greater mobility over a lifetime.1,4,6
INDICATIONS Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, click here.
Join our email list to get exclusive offers and rebates, joint health tips and more!
Your information will be used by American Regent Animal Health to send you news and information about equine osteoarthritis and degenerative joint disease, Adequan® i.m., BetaVet® and other American Regent Animal Health products. We may use your information to help target future content, so we are only sending you relevant information. We will never sell your information to unaffiliated third parties. Once you start receiving news and information, you may opt out from future communications at any time.
